GeneDx Holdings Corp. (WGS)
97.46
+2.82
(+2.98%)
USD |
NASDAQ |
Sep 16, 16:00
97.46
0.00 (0.00%)
After-Hours: 16:25
GeneDx Holdings Enterprise Value : 2.855B for Sept. 15, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 15, 2026 | 2.855B |
| September 14, 2026 | 2.709B |
| September 11, 2026 | 2.576B |
| September 10, 2026 | 2.537B |
| September 09, 2026 | 2.612B |
| September 08, 2026 | 2.594B |
| September 04, 2026 | 2.598B |
| September 03, 2026 | 2.639B |
| September 02, 2026 | 2.619B |
| September 01, 2026 | 2.562B |
| August 31, 2026 | 2.562B |
| August 28, 2026 | 2.608B |
| August 27, 2026 | 2.694B |
| August 26, 2026 | 2.726B |
| August 25, 2026 | 2.640B |
| August 24, 2026 | 2.574B |
| August 21, 2026 | 2.630B |
| August 20, 2026 | 2.495B |
| August 19, 2026 | 2.409B |
| August 18, 2026 | 2.310B |
| August 17, 2026 | 2.341B |
| August 14, 2026 | 2.362B |
| August 13, 2026 | 2.394B |
| August 12, 2026 | 2.490B |
| August 11, 2026 | 2.471B |
| Date | Value |
|---|---|
| August 10, 2026 | 2.356B |
| August 07, 2026 | 2.332B |
| August 06, 2026 | 2.109B |
| August 05, 2026 | 2.118B |
| August 04, 2026 | 2.148B |
| August 03, 2026 | 2.057B |
| July 31, 2026 | 1.975B |
| July 30, 2026 | 2.090B |
| July 29, 2026 | 1.933B |
| July 28, 2026 | 1.879B |
| July 27, 2026 | 1.839B |
| July 24, 2026 | 1.796B |
| July 23, 2026 | 1.924B |
| July 22, 2026 | 1.901B |
| July 21, 2026 | 1.872B |
| July 20, 2026 | 1.842B |
| July 17, 2026 | 1.927B |
| July 16, 2026 | 1.873B |
| July 15, 2026 | 2.006B |
| July 14, 2026 | 1.895B |
| July 13, 2026 | 1.938B |
| July 10, 2026 | 1.991B |
| July 09, 2026 | 2.103B |
| July 08, 2026 | 1.991B |
| July 07, 2026 | 1.985B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| CS Diagnostics Corp. | 0.1202M |
| Aibotics, Inc. | 1.924M |
| Twist Bioscience Corp. | 8.582B |
| GRAIL, Inc. | 2.619B |
| Ayujoy Herbals Ltd. | -- |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -17.74M |
| Revenue (Quarterly) | 114.44M |
| Total Expenses (Quarterly) | 132.18M |
| EPS Diluted (Quarterly) | -0.5971 |
| Gross Profit Margin (Quarterly) | 64.05% |
| Profit Margin (Quarterly) | -15.50% |
| Earnings Yield | -3.72% |
| Normalized Earnings Yield | -2.673 |